Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

6.1.1.11: serine-tRNA ligase

This is an abbreviated version!
For detailed information about serine-tRNA ligase, go to the full flat file.

Word Map on EC 6.1.1.11

Reaction

ATP
+
L-serine
+
tRNASer
=
AMP
+
diphosphate
+
L-seryl-tRNASer

Synonyms

62 kDa RNA-binding protein, bacterial SerRS, bacterial type seryl-tRNA synthetase, bacterial-type SerRS, bMbSerRS, methanogenic SerRS, methanogenic type seryl-tRNA synthetase, methanogenic-type SerRS, methanogenic-type SerRSs, methanogenic-type seryl-tRNA synthetase, mMbSerRS, mSerRS, mtSerRS, SARS, SCSerS, Serine transfer RNA synthetase, Serine translase, Serine--tRNA ligase, SerRS, SerRS1, SerRS2, SerRSmt, serS, SERSEC, seryl tRNA synthetase, Seryl-transfer ribonucleate synthetase, Seryl-transfer ribonucleic acid synthetase, Seryl-transfer RNA synthetase, Seryl-tRNA synthetase, seryl-tRNA synthetase 1, seryl-tRNA synthetase 2, seryl-tRNA-synthetase, SerZMo, STS, subclass IIa dimeric SerRS, SvsR, Synthetase, seryl-transfer ribonucleate, tRNASer/seryl-tRNA synthetase, ttSerRS, TT_C0520, VlmL, ZmSerS

ECTree

     6 Ligases
         6.1 Forming carbon-oxygen bonds
             6.1.1 Ligases forming aminoacyl-tRNA and related compounds
                6.1.1.11 serine-tRNA ligase

Engineering

Engineering on EC 6.1.1.11 - serine-tRNA ligase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
DELTA_C
-
mutant, enzymatically inactive
ko095
-
mutant lacking aminoacylation activity
T429A
SerRSDELTA35-97
-
truncated mutants with a deletion of the N-terminal arm of the enzyme: SerRSDELTA35-97 and SerRSDELTA56-72. Both mutant have lost their specificity for tRNASer and charge also non-cognate type 1 tRNAs. The deletion has no effect on the amino acid activation step of the reaction, but reduces aminoacylation activity dramatically
C117S
the mutant shows increased activity compared to the wild type enzyme
C46S
the mutant shows increased activity compared to the wild type enzyme
DELTAG254-N261
the mutant shows 72% activity compared to the wild type enzyme
DELTAG75-N97
the mutant shows 13% activity compared to the wild type enzyme
DELTAG75-N97/DELTAG254-N261
the mutant shows 7% activity compared to the wild type enzyme
E156T/R157S
the mutant retains about 10% of wild type activity
E447K
the mutant shows increased activity compared to the wild type enzyme
G136V
the mutant retains about 15% of wild type activity
P30G31Y
the mutation of the P30G31 dipeptide to a single tyrosine almost eliminates serylation activity
C315A
-
site-directed mutagenesis
E273A
-
E273A replacement in helix 9 located in the C-terminal domain
E273A/D277A/K280A
-
triple replacement in helix 9
E338A
-
Km (mM)(tRNASer): 0.0021, kcat (1/sec) (tRNASer): 0.059
F397P/A399G
-
the mutant shows deleterious effects in both kcat and KM values compared to the wild type enzyme
G340V/G341A
-
Km (mM)(tRNASer): 0.0067, kcat (1/sec) (tRNASer): 0.000000011
G402A/G405A
-
the double substitution displays an order of magnitude higher KM but only 2.5fold lower kcat
H250A
-
the mutant is highly efficient in serine activation: kcat is reduced by only 3fold, while KM is reduced relative to the wild type parameters
H250A/Q400A
-
the mutant is highly efficient in serine activation: kcat is reduced by only 3fold, while KM is reduced relative to the wild type parameters
K141A
-
mutated enzyme, serylation rate lowered
K164A
-
K164A replacement in the linker peptide
K79A
-
mutated enzyme, significant drop in the serylation rate
K87A
-
mutated enzyme, retains the serylation ability comparable with the wild-type enzyme
K88A
-
mutated enzyme, retains the serylation ability comparable with the wild-type enzyme
K90A
-
mutated enzyme, retains the serylation ability comparable with the wild-type enzyme
mC306A
-
active site mutant
mC306A/C461A
-
active site mutant
mE338A
-
active site mutant
mG340V/G341A
-
active site mutant
mMbSerRS-CTD
-
START codon introduced at position 167, which generates the C-terminal domain
mMbSerRS-CTDDELTAHTH
-
START codon introduced at position 167 of mMbSerRS-DELTAHTH, generating the C-terminal domain without the helix-turn-helix motif
mMbSerRS-DELTAHTH
-
deleted helix-turn-helix motif
mMbSerRS-NTD
-
STOP codon introduced at position 164, which generates the N-terminal domain
mR267A
-
active site mutant
mR347A
-
active site mutant
mW396A
-
active site mutant
N142A
-
mutated enzyme, serylation rate lowered
N435A
-
Km (mM) (L-Ser): 0.07028, kcat (1/sec) (L-Ser): 0.172, Km (mM)(tRNASer): 0.283, kcat (1/sec) (tRNASer): 0.435
N435A/S437A
-
Km (mM) (L-Ser): 0.689, kcat (1/sec) (L-Ser): 0.576, Km (mM)(tRNASer): 0.509, kcat (1/sec) (tRNASer): 0.361
N435A/S437A/W396A
-
Km (mM) (L-Ser): 0.2879, kcat (1/sec) (L-Ser): 1.32, Km (mM)(tRNASer): 1.191, kcat (1/sec) (tRNASer): 0.175
P395A
-
the mutant shows 6.5fold reduced enzyme efficiency compared to the wild type
Q400A
-
the mutation produces only small kinetic effects: KM is elevated 2fold while kcat is reduced 2fold
R143A
-
mutated enzyme, serylation rate lowered
R147A
-
R147A replacement in helix 4 located in the N-terminal domain
R267A
-
Km (mM)(tRNASer): 0.0034, kcat (1/sec) (tRNASer): 0.032
R347A
-
Km (mM)(tRNASer): 0.0063, kcat (1/sec) (tRNASer): 0.0026
R38A
-
mutated enzyme, serylation rate lowered
R76A
-
mutated enzyme, serylation ability completely lost
R78A
-
mutated enzyme, retains the serylation ability comparable with the wild-type enzyme
R94A
-
mutated enzyme, significant drop in the serylation rate
S437A
-
Km (mM) (L-Ser): 0.573, kcat (1/sec) (L-Ser): 0.729, Km (mM)(tRNASer): 0.412, kcat (1/sec) (tRNASer): 0.396
W396A
-
Km (mM)(L-Ser): 0.2645, kcat (1/sec) (L-Ser): 0.287, Km (mM)(tRNASer): 0.760, kcat (1/sec) (tRNASer): 0.239
Y89A
-
mutated enzyme, retains the serylation ability comparable with the wild-type enzyme
A289V
-
mutations in the active site mutant SerRS11, mutant is less sensitive to inhibition by serine hydroxamate and 5'-O-[N-(L-seryl)-sulfamoyl]adenosine
D288Y
-
mutations in the active site mutant SerRS11, mutant is less sensitive to inhibition by serine hydroxamate and 5'-O-[N-(L-seryl)-sulfamoyl]adenosine
E281D/G291A
-
reduced activity compared to the wild-type enzyme
K287R
-
mutations in the active site mutant SerRS12, mutant is less sensitive to inhibition by serine hydroxamate and 5'-O-[N-(L-seryl)-sulfamoyl]adenosine
K287T
-
mutations in the active site mutant SerRS11, mutant is less sensitive to inhibition by serine hydroxamate and 5'-O-[N-(L-seryl)-sulfamoyl]adenosine
ScSerRSDELTAC13
-
mutant containing a deletion of 13 C-terminal residues, mutant is readily complement a ScSerRS null allele, Km and Kcat values comparable to wild-type, T50: 44.5°C, interaction with Pex21p is lost
ScSerRSDELTAC203
-
mutant containing a deletion of 20 C-terminal residues, mutant does not complement a ScSerRS null allele, T50: 44.5°C
H270G
SerRS2 mutant
DELTA2-22
-
in transformed protoplasts, transient expression of deletion mutant reveals GFP fluorescence throughout the cytosol, implying that the very N-terminal region is necessary for the correct targeting of SerZMo into mitochondria and chloroplasts
DELTA2-73
-
transient expression of the SerZMo fusion protein with fully truncated N-terminal extension DELTA2-73 SerZMo-GFP, give diffuse GFP fluorescence throughout the cytosol and shos no association with mitochondria or chloroplasts
DELTA81-511
-
mutant construct containing only the first 80 amino acids is expressed in chloroblasts and in mitochondria as shown by GFP-fusion protein
ZmcSerRSDELTAC12
-
mutant containing a deletion of 12 C-terminal residues, mutant readily complements a yeast SerRS null allele, Km and Kcat values comparable to wild-type
ZmcSerRSDELTAC18
-
mutant containing a deletion of 18 C-terminal residues, mutant readily complements a yeast SerRS null allele, Km and Kcat values comparable to wild-type, T50: 31.5°C, interaction with Pex21p is lost
ZmcSerRSDELTAC26
-
mutant containing a deletion of 26 C-terminal residues, mutant does not complement a yeast SerRS null allele, enzymatic activity of mutant protein is comparable to negative control. Expression of mutant protein is probably severly hindered due to intrinsic instability of the truncated protein
additional information